Glucose transporter 10 and arterial tortuosity syndrome: The vitamin C connection

FEBS Letters

Volumn 584, Issue 14, 2010, Pages 2990-2994

  Segade, Fernando ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arterial tortuosity; Ascorbate; Collagen; Elastin; Glucose transporter

Indexed keywords

ASCORBIC ACID; COLLAGEN; ELASTIN; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 10; OXYGENASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VITAMIN;

AMINO TERMINAL SEQUENCE; ARTERIAL TORTUOSITY SYNDROME; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD VESSEL WALL; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; DISEASE MODEL; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; JOINT HYPERMOBILITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANIMAL; ARTERY; BIOLOGICAL MODEL; GENETICS; MOUSE; MUTATION; REVIEW; SKIN; SYNDROME;

ANIMALS; ARTERIES; ASCORBIC ACID; COLLAGEN; ELASTIN; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; MICE; MODELS, BIOLOGICAL; MUTATION; SKIN; SYNDROME; TRANSFORMING GROWTH FACTOR BETA; VITAMINS;

EID: 77954175024     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.06.011     Document Type: Article

References (49)

1. Jackson Z.S., Dajnowiec D., Gotlieb A.I., Langille B.L. Partial off-loading of longitudinal tension induces arterial tortuosity. Arterioscler. Thromb. Vasc. Biol. 2005, 25:957-962.
2. Hademenos G.J., Massoud T.F. Biophysical mechanisms of stroke. Stroke 1997, 28:2067-2077.
3. Wenn C.M., Newman D.L. Arterial tortuosity. Australas. Phys. Eng. Sci. Med. 1990, 13:67-70.
4. Cartwright M.S., Hickling W.H., Roach E.S. Ischemic stroke in an adolescent with arterial tortuosity syndrome. Neurology 2006, 67:360-361.
5. Del Corso L., et al. Tortuosity, kinking, and coiling of the carotid artery: expression of atherosclerosis or aging?. Angiology 1998, 49:361-371.
6. Dobrin P.B., Schwarcz T.H., Baker W.H. Mechanisms of arterial and aneurysmal tortuosity. Surgery 1988, 104:568-571.
7. Coucke P.J., et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat. Genet. 2006, 38:452-457.
8. Ertugrel A. Diffuse tortuosity and lengthening of the arteries. Circulation 1967, 36:400-407.
9. Wessels M.W., et al. Three new families with arterial tortuosity syndrome. Am. J. Med. Genet. A 2004, 131:134-143.
10. Gardella R., Zoppi N., Assanelli D., Muiesan M.L., Barlati S., Colombi M. Exclusion of candidate genes in a family with arterial tortuosity syndrome. Am. J. Med. Genet. A 2004, 126A:221-228.
11. Callewaert B.L., et al. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum. Mutat. 2008, 29:150-158.
12. Coucke P.J., Wessels M.W., Van Acker P., Gardella R., Barlati S., Willems P.J., Colombi M., De Paepe A. Homozygosity mapping of a gene for arterial tortuosity syndrome to chromosome 20q13. J. Med. Genet. 2003, 40:747-751.
13. Faiyaz-Ul-Haque M., et al. Identification of a p.Ser81Arg encoding mutation in SLC2A10 gene of arterial tortuosity syndrome patients from 10 Qatari families. Clin. Genet. 2008, 74:189-193.
14. Franceschini P., Guala A., Licata D., Di Cara G., Franceschini D. Arterial tortuosity syndrome. Am. J. Med. Genet. 2000, 91:141-143.
15. Akhurst R.J. A sweet link between TGFBeta and vascular disease?. Nat. Genet. 2006, 38:400-401.
16. Manolescu A.R., Witkowska K., Kinnaird A., Cessford T., Cheeseman C. Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 2007, 22:234-240.
17. Thorens B., Mueckler M.M. Glucose transporters in the 21st Century. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E141-E145.
18. Dawson P.A., Mychaleckyj J.C., Fossey S.C., Mihic S.J., Craddock A.L., Bowden D.W. Sequence and functional analysis of GLUT10: a glucose transporter in the type 2 diabetes-linked region of chromosome 20q12-13.1. Mol. Genet. Metab. 2001, 74:186-199.
19. McVie-Wylie A.J., Lamson D.R., Chen Y.T. Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. Genomics 2001, 72:113-117.
20. Wu C., et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009, 10:R130.
21. Wood I.S., Hunter L., Trayhurn P. Expression of class III facilitative glucose transporter genes (GLUT-10 and GLUT-12) in mouse and human adipose tissues. Biochem. Biophys. Res. Commun. 2003, 308:43-49.
22. Bento J.L., Bowden D.W., Mychaleckyj J.C., Hirakawa S., Rich S.S., Freedman B.I., Segade F. Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. BMC Med. Genet. 2005, 6:42.
23. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 2003, 206:2049-2057.
24. Fehr M., Lalonde S., Ehrhardt D.W., Frommer W.B. Live imaging of glucose homeostasis in nuclei of COS-7 cells. J. Fluoresc. 2004, 14:603-609.
25. Stehno-Bittel L., Perez-Terzic C., Clapham D.E. Diffusion across the nuclear envelope inhibited by depletion of the nuclear Ca2+ store. Science 1995, 270:1835-1838.
26. Postic C., Dentin R., Denechaud P.D., Girard J. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu. Rev. Nutr. 2007, 27:179-192.
27. Issad T., Kuo M. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol. Metab. 2008, 19:380-389.
28. Hruz P.W., Mueckler M.M. Cysteine-scanning mutagenesis of transmembrane segment 7 of the GLUT1 glucose transporter. J. Biol. Chem. 1999, 274:36176-36180.
29. Powell K.A., Campbell L.C., Tavare J.M., Leader D.P., Wakefield J.A., Gould G.W. Trafficking of Glut4-green fluorescent protein chimaeras in 3T3-L1 adipocytes suggests distinct internalization mechanisms regulating cell surface glut4 levels. Biochem. J. 1999, 344(Pt 2):535-543.
30. Myllyharju J., Kivirikko K.I. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 2004, 20:33-43.
31. Kielty C.M. Elastic fibres in health and disease. Expert Rev. Mol. Med. 2006, 8:1-23.
32. Linster C.L., Van Schaftingen E. Vitamin C, biosynthesis, recycling and degradation in mammals. FEBS J. 2007, 274:1-22.
33. Englard S., Seifter S. The biochemical functions of ascorbic acid. Annu. Rev. Nutr. 1986, 6:365-406.
34. Liang W.J., Johnson D., Jarvis S.M. Vitamin C transport systems of mammalian cells. Mol. Membr. Biol. 2001, 18:87-95.
35. Banhegyi G., Marcolongo P., Puskas F., Fulceri R., Mandl J., Benedetti A. Dehydroascorbate and ascorbate transport in rat liver microsomal vesicles. J. Biol. Chem. 1998, 273:2758-2762.
36. Nardai G., Braun L., Csala M., Mile V., Csermely P., Benedetti A., Mandl J., Banhegyi G. Protein-disulfide isomerase- and protein thiol-dependent dehydroascorbate reduction and ascorbate accumulation in the lumen of the endoplasmic reticulum. J. Biol. Chem. 2001, 276:8825-8828.
37. Siman C.M., Gittenberger-De Groot A.C., Wisse B., Eriksson U.J. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 2000, 61:355-367.
38. Wren C., Birrell G., Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart 2003, 89:1217-1220.
39. Molin D.G., Roest P.A., Nordstrand H., Wisse L.J., Poelmann R.E., Eriksson U.J., Gittenberger-De Groot A.C. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res. A Clin. Mol. Teratol. 2004, 70:927-938.
40. Siman C.M., Eriksson U.J. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 1997, 40:1416-1424.
41. Ngkeekwong F.C., Ng L.L. Two distinct uptake mechanisms for ascorbate and dehydroascorbate in human lymphoblasts and their interaction with glucose. Biochem. J. 1997, 324(Pt 1):225-230.
42. Maeda N., Hagihara H., Nakata Y., Hiller S., Wilder J., Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc. Natl. Acad. Sci. USA 2000, 97:841-846.
43. Wagenseil J.E., Nerurkar N.L., Knutsen R.H., Okamoto R.J., Li D.Y., Mecham R.P. Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1209-H1217.
44. Nakamura T., et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002, 415:171-175.
45. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 2003, 116:217-224.
46. Neptune E.R., et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 2003, 33:407-411.
47. Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., Eichwald E., Keating M.T. Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393:276-280.
48. Cheng C.H., Kikuchi T., Chen Y.H., Sabbagha N.G., Lee Y.C., Pan H.J., Chang C., Chen Y.T. Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc. Res. 2009, 81:381-388.
49. Callewaert B.L., et al. Absence of arterial phenotype in mice with homozygous slc2A10 missense substitutions. Genesis 2008, 46:385-389.